The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AAV Plasmid Market Research Report 2025
Synopsis
AAV plasmids (adeno-associated virus plasmids) are the primary viral vectors used in in vivo gene therapy clinical trials due to their high efficiency and enhanced safety in humans.
The global AAV Plasmid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for AAV Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AAV Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AAV Plasmid in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AAV Plasmid include PlasmidFactory GmbH, GeneCopoeia, Thermo Fisher Scientific, OriGene, Takara Bio, Azenta Life Sciences, Sartorius, Aldevron and Omega Bio Tek, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AAV Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AAV Plasmid.
Report Scope
The AAV Plasmid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AAV Plasmid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AAV Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PlasmidFactory GmbH
GeneCopoeia
Thermo Fisher Scientific
OriGene
Takara Bio
Azenta Life Sciences
Sartorius
Aldevron
Omega Bio Tek
Addgene
Viral Vector Core
Azenta
OXGENE
Segment by Type
AAV Plasmids with C-terminal TGFP Tag
AAV Plasmid with C-terminal TRFP Tag
Segment by Application
Laboratory
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AAV Plasmid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
AAV plasmids (adeno-associated virus plasmids) are the primary viral vectors used in in vivo gene therapy clinical trials due to their high efficiency and enhanced safety in humans.
The global AAV Plasmid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for AAV Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AAV Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AAV Plasmid in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AAV Plasmid include PlasmidFactory GmbH, GeneCopoeia, Thermo Fisher Scientific, OriGene, Takara Bio, Azenta Life Sciences, Sartorius, Aldevron and Omega Bio Tek, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AAV Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AAV Plasmid.
Report Scope
The AAV Plasmid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AAV Plasmid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AAV Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PlasmidFactory GmbH
GeneCopoeia
Thermo Fisher Scientific
OriGene
Takara Bio
Azenta Life Sciences
Sartorius
Aldevron
Omega Bio Tek
Addgene
Viral Vector Core
Azenta
OXGENE
Segment by Type
AAV Plasmids with C-terminal TGFP Tag
AAV Plasmid with C-terminal TRFP Tag
Segment by Application
Laboratory
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AAV Plasmid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AAV Plasmid Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 AAV Plasmids with C-terminal TGFP Tag
1.2.3 AAV Plasmid with C-terminal TRFP Tag
1.3 Market by Application
1.3.1 Global AAV Plasmid Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AAV Plasmid Market Perspective (2019-2030)
2.2 AAV Plasmid Growth Trends by Region
2.2.1 Global AAV Plasmid Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AAV Plasmid Historic Market Size by Region (2019-2024)
2.2.3 AAV Plasmid Forecasted Market Size by Region (2025-2030)
2.3 AAV Plasmid Market Dynamics
2.3.1 AAV Plasmid Industry Trends
2.3.2 AAV Plasmid Market Drivers
2.3.3 AAV Plasmid Market Challenges
2.3.4 AAV Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AAV Plasmid Players by Revenue
3.1.1 Global Top AAV Plasmid Players by Revenue (2019-2024)
3.1.2 Global AAV Plasmid Revenue Market Share by Players (2019-2024)
3.2 Global AAV Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AAV Plasmid Revenue
3.4 Global AAV Plasmid Market Concentration Ratio
3.4.1 Global AAV Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AAV Plasmid Revenue in 2023
3.5 AAV Plasmid Key Players Head office and Area Served
3.6 Key Players AAV Plasmid Product Solution and Service
3.7 Date of Enter into AAV Plasmid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AAV Plasmid Breakdown Data by Type
4.1 Global AAV Plasmid Historic Market Size by Type (2019-2024)
4.2 Global AAV Plasmid Forecasted Market Size by Type (2025-2030)
5 AAV Plasmid Breakdown Data by Application
5.1 Global AAV Plasmid Historic Market Size by Application (2019-2024)
5.2 Global AAV Plasmid Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AAV Plasmid Market Size (2019-2030)
6.2 North America AAV Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AAV Plasmid Market Size by Country (2019-2024)
6.4 North America AAV Plasmid Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AAV Plasmid Market Size (2019-2030)
7.2 Europe AAV Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AAV Plasmid Market Size by Country (2019-2024)
7.4 Europe AAV Plasmid Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AAV Plasmid Market Size (2019-2030)
8.2 Asia-Pacific AAV Plasmid Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AAV Plasmid Market Size by Region (2019-2024)
8.4 Asia-Pacific AAV Plasmid Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AAV Plasmid Market Size (2019-2030)
9.2 Latin America AAV Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AAV Plasmid Market Size by Country (2019-2024)
9.4 Latin America AAV Plasmid Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AAV Plasmid Market Size (2019-2030)
10.2 Middle East & Africa AAV Plasmid Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AAV Plasmid Market Size by Country (2019-2024)
10.4 Middle East & Africa AAV Plasmid Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PlasmidFactory GmbH
11.1.1 PlasmidFactory GmbH Company Detail
11.1.2 PlasmidFactory GmbH Business Overview
11.1.3 PlasmidFactory GmbH AAV Plasmid Introduction
11.1.4 PlasmidFactory GmbH Revenue in AAV Plasmid Business (2019-2024)
11.1.5 PlasmidFactory GmbH Recent Development
11.2 GeneCopoeia
11.2.1 GeneCopoeia Company Detail
11.2.2 GeneCopoeia Business Overview
11.2.3 GeneCopoeia AAV Plasmid Introduction
11.2.4 GeneCopoeia Revenue in AAV Plasmid Business (2019-2024)
11.2.5 GeneCopoeia Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific AAV Plasmid Introduction
11.3.4 Thermo Fisher Scientific Revenue in AAV Plasmid Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 OriGene
11.4.1 OriGene Company Detail
11.4.2 OriGene Business Overview
11.4.3 OriGene AAV Plasmid Introduction
11.4.4 OriGene Revenue in AAV Plasmid Business (2019-2024)
11.4.5 OriGene Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio AAV Plasmid Introduction
11.5.4 Takara Bio Revenue in AAV Plasmid Business (2019-2024)
11.5.5 Takara Bio Recent Development
11.6 Azenta Life Sciences
11.6.1 Azenta Life Sciences Company Detail
11.6.2 Azenta Life Sciences Business Overview
11.6.3 Azenta Life Sciences AAV Plasmid Introduction
11.6.4 Azenta Life Sciences Revenue in AAV Plasmid Business (2019-2024)
11.6.5 Azenta Life Sciences Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Detail
11.7.2 Sartorius Business Overview
11.7.3 Sartorius AAV Plasmid Introduction
11.7.4 Sartorius Revenue in AAV Plasmid Business (2019-2024)
11.7.5 Sartorius Recent Development
11.8 Aldevron
11.8.1 Aldevron Company Detail
11.8.2 Aldevron Business Overview
11.8.3 Aldevron AAV Plasmid Introduction
11.8.4 Aldevron Revenue in AAV Plasmid Business (2019-2024)
11.8.5 Aldevron Recent Development
11.9 Omega Bio Tek
11.9.1 Omega Bio Tek Company Detail
11.9.2 Omega Bio Tek Business Overview
11.9.3 Omega Bio Tek AAV Plasmid Introduction
11.9.4 Omega Bio Tek Revenue in AAV Plasmid Business (2019-2024)
11.9.5 Omega Bio Tek Recent Development
11.10 Addgene
11.10.1 Addgene Company Detail
11.10.2 Addgene Business Overview
11.10.3 Addgene AAV Plasmid Introduction
11.10.4 Addgene Revenue in AAV Plasmid Business (2019-2024)
11.10.5 Addgene Recent Development
11.11 Viral Vector Core
11.11.1 Viral Vector Core Company Detail
11.11.2 Viral Vector Core Business Overview
11.11.3 Viral Vector Core AAV Plasmid Introduction
11.11.4 Viral Vector Core Revenue in AAV Plasmid Business (2019-2024)
11.11.5 Viral Vector Core Recent Development
11.12 Azenta
11.12.1 Azenta Company Detail
11.12.2 Azenta Business Overview
11.12.3 Azenta AAV Plasmid Introduction
11.12.4 Azenta Revenue in AAV Plasmid Business (2019-2024)
11.12.5 Azenta Recent Development
11.13 OXGENE
11.13.1 OXGENE Company Detail
11.13.2 OXGENE Business Overview
11.13.3 OXGENE AAV Plasmid Introduction
11.13.4 OXGENE Revenue in AAV Plasmid Business (2019-2024)
11.13.5 OXGENE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global AAV Plasmid Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of AAV Plasmids with C-terminal TGFP Tag
Table 3. Key Players of AAV Plasmid with C-terminal TRFP Tag
Table 4. Global AAV Plasmid Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global AAV Plasmid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global AAV Plasmid Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global AAV Plasmid Market Share by Region (2019-2024)
Table 8. Global AAV Plasmid Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global AAV Plasmid Market Share by Region (2025-2030)
Table 10. AAV Plasmid Market Trends
Table 11. AAV Plasmid Market Drivers
Table 12. AAV Plasmid Market Challenges
Table 13. AAV Plasmid Market Restraints
Table 14. Global AAV Plasmid Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global AAV Plasmid Market Share by Players (2019-2024)
Table 16. Global Top AAV Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Plasmid as of 2023)
Table 17. Ranking of Global Top AAV Plasmid Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by AAV Plasmid Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players AAV Plasmid Product Solution and Service
Table 21. Date of Enter into AAV Plasmid Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global AAV Plasmid Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global AAV Plasmid Revenue Market Share by Type (2019-2024)
Table 25. Global AAV Plasmid Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global AAV Plasmid Revenue Market Share by Type (2025-2030)
Table 27. Global AAV Plasmid Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global AAV Plasmid Revenue Market Share by Application (2019-2024)
Table 29. Global AAV Plasmid Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global AAV Plasmid Revenue Market Share by Application (2025-2030)
Table 31. North America AAV Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America AAV Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America AAV Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe AAV Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe AAV Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe AAV Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific AAV Plasmid Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific AAV Plasmid Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific AAV Plasmid Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America AAV Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America AAV Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America AAV Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa AAV Plasmid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa AAV Plasmid Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa AAV Plasmid Market Size by Country (2025-2030) & (US$ Million)
Table 46. PlasmidFactory GmbH Company Detail
Table 47. PlasmidFactory GmbH Business Overview
Table 48. PlasmidFactory GmbH AAV Plasmid Product
Table 49. PlasmidFactory GmbH Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 50. PlasmidFactory GmbH Recent Development
Table 51. GeneCopoeia Company Detail
Table 52. GeneCopoeia Business Overview
Table 53. GeneCopoeia AAV Plasmid Product
Table 54. GeneCopoeia Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 55. GeneCopoeia Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific AAV Plasmid Product
Table 59. Thermo Fisher Scientific Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. OriGene Company Detail
Table 62. OriGene Business Overview
Table 63. OriGene AAV Plasmid Product
Table 64. OriGene Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 65. OriGene Recent Development
Table 66. Takara Bio Company Detail
Table 67. Takara Bio Business Overview
Table 68. Takara Bio AAV Plasmid Product
Table 69. Takara Bio Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 70. Takara Bio Recent Development
Table 71. Azenta Life Sciences Company Detail
Table 72. Azenta Life Sciences Business Overview
Table 73. Azenta Life Sciences AAV Plasmid Product
Table 74. Azenta Life Sciences Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 75. Azenta Life Sciences Recent Development
Table 76. Sartorius Company Detail
Table 77. Sartorius Business Overview
Table 78. Sartorius AAV Plasmid Product
Table 79. Sartorius Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 80. Sartorius Recent Development
Table 81. Aldevron Company Detail
Table 82. Aldevron Business Overview
Table 83. Aldevron AAV Plasmid Product
Table 84. Aldevron Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 85. Aldevron Recent Development
Table 86. Omega Bio Tek Company Detail
Table 87. Omega Bio Tek Business Overview
Table 88. Omega Bio Tek AAV Plasmid Product
Table 89. Omega Bio Tek Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 90. Omega Bio Tek Recent Development
Table 91. Addgene Company Detail
Table 92. Addgene Business Overview
Table 93. Addgene AAV Plasmid Product
Table 94. Addgene Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 95. Addgene Recent Development
Table 96. Viral Vector Core Company Detail
Table 97. Viral Vector Core Business Overview
Table 98. Viral Vector Core AAV Plasmid Product
Table 99. Viral Vector Core Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 100. Viral Vector Core Recent Development
Table 101. Azenta Company Detail
Table 102. Azenta Business Overview
Table 103. Azenta AAV Plasmid Product
Table 104. Azenta Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 105. Azenta Recent Development
Table 106. OXGENE Company Detail
Table 107. OXGENE Business Overview
Table 108. OXGENE AAV Plasmid Product
Table 109. OXGENE Revenue in AAV Plasmid Business (2019-2024) & (US$ Million)
Table 110. OXGENE Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AAV Plasmid Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global AAV Plasmid Market Share by Type: 2023 VS 2030
Figure 3. AAV Plasmids with C-terminal TGFP Tag Features
Figure 4. AAV Plasmid with C-terminal TRFP Tag Features
Figure 5. Global AAV Plasmid Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global AAV Plasmid Market Share by Application: 2023 VS 2030
Figure 7. Laboratory Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. AAV Plasmid Report Years Considered
Figure 11. Global AAV Plasmid Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global AAV Plasmid Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global AAV Plasmid Market Share by Region: 2023 VS 2030
Figure 14. Global AAV Plasmid Market Share by Players in 2023
Figure 15. Global Top AAV Plasmid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Plasmid as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by AAV Plasmid Revenue in 2023
Figure 17. North America AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America AAV Plasmid Market Share by Country (2019-2030)
Figure 19. United States AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe AAV Plasmid Market Share by Country (2019-2030)
Figure 23. Germany AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific AAV Plasmid Market Share by Region (2019-2030)
Figure 31. China AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America AAV Plasmid Market Share by Country (2019-2030)
Figure 39. Mexico AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa AAV Plasmid Market Share by Country (2019-2030)
Figure 43. Turkey AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia AAV Plasmid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. PlasmidFactory GmbH Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 46. GeneCopoeia Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 48. OriGene Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 49. Takara Bio Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 50. Azenta Life Sciences Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 51. Sartorius Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 52. Aldevron Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 53. Omega Bio Tek Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 54. Addgene Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 55. Viral Vector Core Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 56. Azenta Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 57. OXGENE Revenue Growth Rate in AAV Plasmid Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
